Tuberculosis (TB) is the leading cause of death for people living with HIV (PLHIV), affecting 10 million people worldwide and resulting in more than 1.5 million deaths in 2020. Integrating TB preventive treatment (TPT) into the fact-track (FT) model could ensure PLHIV...
Article and Study Summary: Dolutegravir as First- or Second-line Treatment for HIV-1 Infection in Children Published in: New England Journal of Medicine 2021,385(27):2531-2543. https://www.nejm.org/doi/full/10.1056/NEJMoa2108793 Authors: Turkova A, White E, Mujuru HA,...
Article and Study Summary: Treating Depression and Improving Adherence in HIV Care with Task-Shared Cognitive Behavioural Therapy in Khayelitsha, South Africa: A Randomized Controlled Trial Published in: Journal of the International AIDS Society 2021, 24:e25823....
Authors: Zoe Ward, Jack Stone, Chrissy Bishop, Viktor Ivakin, Ksenia Eritsyan, Anna Deryabina, Andrea Low, Javier Cepeda, Sherrie L Kelly, Robert Heimer, Robert Cook, Frederick L Altice, Taylor Litz, Assel Terlikbayeva, Nabila El-Bassel, Denis Havarkov, Alena Fisenka,...
Article and Study Summary: Dolutegravir or Darunavir in Combination with Zidovudine or Tenofovir to Treat HIV. Published in: N Engl J Med 2021;385(4):330-341. https://www.nejm.org/doi/full/10.1056/NEJMoa2101609 Authors: Paton NI, Musaazi J, Kityo C, et al. Summary:...